首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport
【2h】

Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport

机译:MDR1转染的野生型细胞系与野生型细胞系中内源性外向转运蛋白表达的差异会影响P-糖蛋白介导的药物转运

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and purpose:P-glycoprotein (Pgp) efflux assays are widely used to identify Pgp substrates. The kidney cell lines Madin-Darby canine kidney (MDCK)-II and LLC-PK1, transfected with human MDR1 (ABCB1) are used to provide recombinant models of drug transport. Endogenous transporters in these cells may contribute to the activities of recombinant transporters, so that drug transport in MDR1-transfected cells is often corrected for the transport obtained in parental (wildtype) cells. However, expression of endogenous transporters may vary between transfected and wildtype cells, so that this correction may cause erroneous data. Here, we have measured the expression of endogenous efflux transporters in transfected and wildtype MDCK-II or LLC cells and the consequences for Pgp-mediated drug transport.
机译:背景与目的:P-糖蛋白(Pgp)外排测定法广泛用于鉴定Pgp底物。用人MDR1(ABCB1)转染的肾细胞系Madin-Darby犬肾(MDCK)-II和LLC-PK1用于提供药物转运的重组模型。这些细胞中的内源性转运蛋白可能有助于重组转运蛋白的活性,因此,对于在MDR1转染的细胞中的药物转运,通常会针对在亲本(野生型)细胞中获得的转运进行校正。但是,内源转运蛋白的表达可能会在转染的细胞和野生型细胞之间发生变化,因此这种校正可能会导致错误的数据。在这里,我们已经测量了内源性外源转运蛋白在转染的和野生型MDCK-II或LLC细胞中的表达以及Pgp介导的药物转运的后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号